Literature DB >> 19179627

Small molecule inhibitors of divalent metal transporter-1.

Peter D Buckett1, Marianne Wessling-Resnick.   

Abstract

Divalent metal transporter-1 (DMT1) is a divalent cation transporter that plays a key role in iron metabolism by mediating ferrous iron uptake across the small intestine. We have previously identified several small molecule inhibitors of iron uptake (4). Using a cell line that stably overexpresses DMT1, we screened the ability of these inhibitors to specifically block this transporter's activity. One compound, NSC306711, inhibited DMT1-mediated iron uptake in a reversible and competitive manner. This inhibitor is a polysulfonated dye containing two copper centers. Although one of these two sites could be chelated by Triethylenetetramine copper chelation did not perturb NSC306711 inhibition of DMT1 activity. Several other polysulfonated dyes with structural features similar to NSC306711 were identified as potential DMT1 transport inhibitors. This study characterizes important pharmacological tools that can be used to probe DMT1's mechanism of iron transport and its role in iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179627      PMCID: PMC2670682          DOI: 10.1152/ajpgi.90342.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  15 in total

Review 1.  Secondary iron overload.

Authors:  J P Kushner; J P Porter; N F Olivieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2001

2.  Identification of small molecule inhibitors that distinguish between non-transferrin bound iron uptake and transferrin-mediated iron transport.

Authors:  Jing Xu Brown; Peter D Buckett; Marianne Wessling-Resnick
Journal:  Chem Biol       Date:  2004-03

3.  DMT1: which metals does it transport?

Authors:  Michael D Garrick; Steven T Singleton; Farida Vargas; H-C Kuo; Lin Zhao; Martin Knöpfel; Todd Davidson; Max Costa; Prasad Paradkar; Jerome A Roth; Laura M Garrick
Journal:  Biol Res       Date:  2006       Impact factor: 5.612

4.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport.

Authors:  M D Fleming; M A Romano; M A Su; L M Garrick; M D Garrick; N C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 5.  HFE and non-HFE hemochromatosis.

Authors:  Gregory J Anderson; Lawrie W Powell
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

6.  Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene.

Authors:  M D Fleming; C C Trenor; M A Su; D Foernzler; D R Beier; W F Dietrich; N C Andrews
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

7.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter.

Authors:  H Gunshin; B Mackenzie; U V Berger; Y Gunshin; M F Romero; W F Boron; S Nussberger; J L Gollan; M A Hediger
Journal:  Nature       Date:  1997-07-31       Impact factor: 49.962

8.  Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool.

Authors:  V Picard; G Govoni; N Jabado; P Gros
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

9.  Iron and transition metal transport into erythrocytes mediated by nifedipine degradation products and related compounds.

Authors:  Donna L Savigni; Dieter Wege; Garth S Cliff; Mark L H Meesters; Evan H Morgan
Journal:  Biochem Pharmacol       Date:  2003-04-15       Impact factor: 5.858

10.  The small-molecule iron transport inhibitor ferristatin/NSC306711 promotes degradation of the transferrin receptor.

Authors:  Lior Horonchik; Marianne Wessling-Resnick
Journal:  Chem Biol       Date:  2008-07-21
View more
  17 in total

1.  Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial.

Authors:  Erlin Zhang; Haiyan Chen; Feng Shen
Journal:  J Mater Sci Mater Med       Date:  2010-04-16       Impact factor: 3.896

2.  The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro.

Authors:  Ahmed A Alkhateeb; Peter D Buckett; Andrew M Gardeck; Jonghan Kim; Shaina L Byrne; Paula G Fraenkel; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-04-23       Impact factor: 4.052

3.  The Divalent Metal Transporter 1 (DMT1) Is Required for Iron Uptake and Normal Development of Oligodendrocyte Progenitor Cells.

Authors:  Veronica T Cheli; Diara A Santiago González; Leandro N Marziali; Norma N Zamora; María E Guitart; Vilma Spreuer; Juana M Pasquini; Pablo M Paez
Journal:  J Neurosci       Date:  2018-09-06       Impact factor: 6.167

Review 4.  Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways.

Authors:  Gajendra Kumar Azad; Raghuvir S Tomar
Journal:  Mol Biol Rep       Date:  2014-08       Impact factor: 2.316

Review 5.  Pharmacology of iron transport.

Authors:  Shaina L Byrne; Divya Krishnamurthy; Marianne Wessling-Resnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-09-27       Impact factor: 13.820

6.  Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro.

Authors:  Julia Bornhorst; Christoph A Wehe; Sabine Hüwel; Uwe Karst; Hans-Joachim Galla; Tanja Schwerdtle
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

7.  Human iron transporters.

Authors:  Michael D Garrick
Journal:  Genes Nutr       Date:  2010-09-14       Impact factor: 5.523

8.  Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia.

Authors:  Erik R Anderson; Matthew Taylor; Xiang Xue; Sadeesh K Ramakrishnan; Angelical Martin; Liwei Xie; Bryce X Bredell; Sara Gardenghi; Stefano Rivella; Yatrik M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

9.  Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.

Authors:  Jonghan Kim; Xuming Jia; Peter D Buckett; Sihao Liu; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2012-12-14       Impact factor: 5.191

Review 10.  H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.

Authors:  Ali Shawki; Patrick B Knight; Bryan D Maliken; Eric J Niespodzany; Bryan Mackenzie
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.